Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Tax Provisions (2022 - 2025)

GeneDx Holdings (WGS) has disclosed Tax Provisions for 4 consecutive years, with -$548000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Tax Provisions changed N/A to -$548000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$100000.0, a 68.65% increase, with the full-year FY2025 number at -$100000.0, up 66.67% from a year prior.
  • Tax Provisions was -$548000.0 for Q4 2025 at GeneDx Holdings, down from $248000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $447000.0 in Q1 2025 to a low of -$49.1 million in Q2 2022.
  • A 4-year average of -$3.6 million and a median of -$159500.0 in 2023 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: tumbled 1114.29% in 2023, then surged 645.12% in 2025.
  • GeneDx Holdings' Tax Provisions stood at $42000.0 in 2022, then crashed by 1114.29% to -$426000.0 in 2023, then soared by 88.97% to -$47000.0 in 2024, then tumbled by 1065.96% to -$548000.0 in 2025.
  • Per Business Quant, the three most recent readings for WGS's Tax Provisions are -$548000.0 (Q4 2025), $248000.0 (Q3 2025), and -$247000.0 (Q2 2025).